Scapho 150mg Injection

Prezentare produs

About Scapho

Scapho is a medication containing the active ingredient Secukinumab, classified as Interleukin-17A Antagonist. Secukinumab, sold under the brand name Cosentyx among others, is a human IgG1κ monoclonal antibody used for the treatment of psoriasis, ankylosing spondylitis, psoriatic arthritis, and hidradenitis suppurativa. It binds to the protein interleukin (IL)-17A and is marketed by Novartis.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE COSENTYX is a human interleukin-17A antagonist indicated for the treatment of: moderate to severe plaque psoriasis (PsO) in.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Secukinumab, the active ingredient in Scapho, belongs to the Interleukin-17A Antagonist class. 1 INDICATIONS AND USAGE COSENTYX is a human interleukin-17A antagonist indicated for the treatment of: moderate to severe plaque psoriasis (PsO) in adults and pediatric patients 6 years and older who are candidates for systemic therapy or phototherapy. ( 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Scapho. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Scapho for extended periods without medical advice.